Carregant...
Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma
BACKGROUND: The need for new therapies for cholangiocarcinoma is highlighted by their poor prognosis and refractoriness to chemotherapy. Increased production of Interleukin-6 promotes cholangiocarcinoma growth and contributes to chemoresistance by activating cell survival mechanisms. We sought to id...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002961/ https://ncbi.nlm.nih.gov/pubmed/21179572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0015195 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|